Kliniken Essen-Mitte Evang. Huyssens-Stiftung

Essen 45136

0 studies enrolling now · 3 studies all time

What they study most

HER2 Positive Breast Cancer, Hepatocellular Carcinoma (HCC), Pancreatic Ductal Carcinoma

Studies at this site

• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early